A molecular genetic test (FLT3 D835 Point Mutation Analysis Test) that detects specific gene mutations or fusions in blood or bone marrow cells.
Used in acute myeloid leukaemia (AML) — to classify the disease, predict outlook and choose targeted treatment.
People being evaluated or treated for cancer, or as advised by an oncologist. Not a stand-alone screening test.
No fasting needed.
This article is for general information and education only. It is not medical advice, does not create a doctor–patient relationship, and is not a substitute for consultation with a qualified doctor who has assessed your individual situation. Never delay seeking medical advice because of something you have read here.
In a medical emergency, call 112, or 108 for an ambulance where that service operates, or go to your nearest emergency department. If you are in mental health distress, Tele-MANAS is free and available 24×7 on 14416.
Read our Editorial Policy and Medical Review Process.
No fasting is needed. You can eat and drink normally unless your doctor has advised otherwise.
Blood or bone marrow sample (EDTA/heparin tube) as advised by your haematologist.
Usually about 3–4 days after the sample reaches the lab. You will receive the report online.